Drug Shortage Report for ROFACT

Last updated on 2023-03-27 History
Report ID 186883
Drug Identification Number 00343617
Brand name ROFACT
Common or Proper name Rofact
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) RIFAMPIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 300
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-03-27
Actual start date
Estimated end date 2023-04-03
Actual end date 2023-03-24
Shortage status Avoided shortage
Updated date 2023-03-27
Company comments Delays in outside lab testing
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2023-03-27 French Compare
v3 2023-03-27 English Compare
v2 2023-03-13 French Compare
v1 2023-03-13 English Compare

Showing 1 to 4 of 4